Pyrogens refer to those substances which cause fever after administration of injection. Rise in the temperature of human body as well as body ache are some of the major reactions caused owing to the injection of harmful pyrogens in the body. Pyrogen testing helps in determination of the presence of endotoxin substances present in the human body. The pyrogen testing market can be segmented on the basis of application, test type, end-user and regions. The rising support especially from governments of various economies in order to launch new and more innovative drug options to fight with several new types of diseases has bolstered the overall demand for pyrogen testing products in the recent past. In addition to this, pyrogens are widely known as a major cause to body ache and fever after being injected into the human body. This testing of pyrogens helps in easy identification of the presence of endotoxin substances and is being widely used especially in the development of improved and new drugs across the globe.
Increasing growth of global pyrogen testing market is primarily anticipated to be the result of increasing number of biotechnology and pharmaceutical companies across the globe. In addition, increasing investments in research and development activities as well as rising approvals for new and improved drugs is another major factor bolstering the growth of pyrogen testing market, globally. Also, other factors such as increasing prevalence of chronic diseases, rising healthcare expenditure and favorable government support programs and initiatives are further augmenting the growth of global pyrogen testing market over the forecast period. However, factors such as high barrier for new market entrants is one of the key aspects anticipated to hamper the growth of pyrogen testing market over the forecast period. On the other hand, increasing medical tourism, especially in developing regions such as Latin America and Asia-Pacific, coupled with a rapidly growing healthcare industry in emerging economies such as India, China, Japan, Indonesia, Argentina, and Brazil among others are considered to be the future landscape for global pyrogen testing market over the forecast period. Moreover, increasing discovery of new and more innovative drugs along with huge investments in overall sunk costs, especially by biotechnological and pharmaceutical companies, coupled with rising support by the governments of various economies across the globe in healthcare sector are some other elements fueling the growth of pyrogen testing market.
The global pyrogen testing market can be segmented on the basis of application, product type and geography. On the basis of application, the global pyrogen testing market can be segmented into pharmaceuticals and biotechnology, medical devices manufacturing and others. By product type, the global pyrogen testing market can be segmented into kits & reagents, services and instruments. On the basis of region, the global pyrogen testing market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific. The demand in Asia-Pacific is analyzed to be the major driving factor for the growth of the pyrogen testing market. China is analyzed to lead the demand for pyrogen testing due to increased industrial production in the past half decade. The markets in emerging economies such as Brazil and India are also projected to grow rapidly.
Key players involved in the global pyrogen testing market are focusing on key market strategies such as acquisitions and mergers with local as well as established players. Moreover, companies are also focusing on collaborating with local players to increase their reach across all geographies and earn huge profits. Partnership with multinational companies to strengthen their market reach and goodwill is also anticipated to be a major market strategy in the global pyrogen testing market. Some of the major players involved in the manufacture and supply of pyrogen testing include Hyglos GmbH, Associates of Cape Cod Inc, GenScript, Wako Chemicals USA Inc., Charles River Laboratories International Inc.,Ellab A/S, Merck & Co Inc., Lonza Group, Sigma-Aldrich Corporation, and Thermo Fisher Scientific Inc.
Market by Product
· Kits & reagents
Market by Application
· Pharmaceuticals and biotechnology
· Medical devices manufacturing
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights Nonwovens are a unique category of textile product enginee
According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o
According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments. Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The
According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights An gr
Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes
Introduction According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i